$1.35 Billion is the total value of First Light Asset Management, LLC's 74 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 46.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CDNA | Sell | CAREDX INC | $129,514,000 | +80.6% | 1,787,637 | -5.4% | 9.58% | +30.4% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $109,846,000 | +119.2% | 2,571,892 | +34.9% | 8.13% | +58.3% |
| SPNE | Buy | SEASPINE HLDGS CORP | $93,384,000 | +27.9% | 5,351,493 | +4.8% | 6.91% | -7.6% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $86,393,000 | +59.2% | 4,946,629 | +6.6% | 6.39% | +14.9% |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $54,052,000 | +332.1% | 704,449 | +142.5% | 4.00% | +211.9% |
| OMCL | Buy | OMNICELL COM | $52,838,000 | +68.4% | 440,246 | +4.7% | 3.91% | +21.5% |
| GKOS | Buy | GLAUKOS CORP | $51,049,000 | +58.5% | 678,307 | +4.3% | 3.78% | +14.5% |
| MODN | Buy | MODEL N INC | $46,741,000 | +42.2% | 1,310,013 | +40.6% | 3.46% | +2.6% |
| ATRC | Buy | ATRICURE INC | $45,054,000 | +101.3% | 809,310 | +44.3% | 3.33% | +45.3% |
| HCAT | Buy | HEALTH CATALYST INC | $42,307,000 | +361.0% | 971,897 | +287.6% | 3.13% | +233.0% |
| AXGN | Buy | AXOGEN INC | $38,290,000 | +90.4% | 2,139,134 | +23.7% | 2.83% | +37.5% |
| INSM | Buy | INSMED INC | $35,661,000 | +8.2% | 1,071,219 | +4.5% | 2.64% | -21.9% |
| KRMD | Sell | REPRO MED SYS INC | $35,346,000 | -32.5% | 5,871,364 | -19.1% | 2.62% | -51.3% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTD | $32,727,000 | +95.3% | 3,391,412 | +82.3% | 2.42% | +41.0% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $31,471,000 | +34.8% | 635,652 | +4.5% | 2.33% | -2.7% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $29,608,000 | +94.8% | 213,887 | +15.6% | 2.19% | +40.6% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $29,504,000 | +47.5% | 491,740 | +5.8% | 2.18% | +6.5% |
| XENT | Buy | INTERSECT ENT INC | $28,006,000 | +44.5% | 1,222,961 | +2.9% | 2.07% | +4.3% |
| NEO | Sell | NEOGENOMICS INC | $27,840,000 | +23.1% | 517,091 | -15.7% | 2.06% | -11.1% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $26,597,000 | – | 1,563,618 | +100.0% | 1.97% | – |
| GMAB | Buy | GENMAB A/S | $25,904,000 | +17.2% | 637,084 | +5.5% | 1.92% | -15.4% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $25,573,000 | -12.4% | 267,274 | +3.9% | 1.89% | -36.7% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $24,737,000 | +24.7% | 321,967 | +21.3% | 1.83% | -10.0% |
| PRTA | New | PROTHENA CORP PLC | $24,698,000 | – | 2,056,453 | +100.0% | 1.83% | – |
| OPRX | Buy | OPTIMIZERX CORP | $21,366,000 | +73.7% | 685,700 | +16.2% | 1.58% | +25.5% |
| CDXS | Sell | CODEXIS INC | $21,013,000 | +80.7% | 962,591 | -2.8% | 1.56% | +30.6% |
| SIBN | Buy | SI BONE INC | $20,152,000 | +27.0% | 673,982 | +0.7% | 1.49% | -8.3% |
| STRO | New | SUTRO BIOPHARMA INC | $17,956,000 | – | 827,101 | +100.0% | 1.33% | – |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $13,958,000 | +40.8% | 137,400 | +7.2% | 1.03% | +1.7% |
| QDEL | Buy | QUIDEL CORP | $11,621,000 | -6.6% | 64,686 | +14.0% | 0.86% | -32.5% |
| KIDS | Buy | ORTHOPEDIATRICS CORP | $11,570,000 | +12.5% | 280,477 | +25.2% | 0.86% | -18.8% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $10,328,000 | – | 368,200 | +100.0% | 0.76% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $10,155,000 | – | 179,601 | +100.0% | 0.75% | – |
| MEIP | Buy | MEI PHARMA INC | $10,014,000 | -14.7% | 3,793,275 | +0.8% | 0.74% | -38.4% |
| ZYME | Buy | ZYMEWORKS INC | $9,343,000 | +2.9% | 197,702 | +1.4% | 0.69% | -25.8% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $8,576,000 | +17.5% | 51,962 | +1.6% | 0.63% | -15.2% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $6,785,000 | +41.6% | 55,681 | +1.5% | 0.50% | +2.2% |
| SLP | Buy | SIMULATIONS PLUS INC | $5,158,000 | -3.4% | 71,719 | +1.3% | 0.38% | -30.2% |
| JYNT | New | JOINT CORP | $5,097,000 | – | 194,105 | +100.0% | 0.38% | – |
| VAPO | Buy | VAPOTHERM INC | $5,100,000 | -6.7% | 189,862 | +0.7% | 0.38% | -32.7% |
| MASS | New | 908 DEVICES INC | $4,556,000 | – | 80,000 | +100.0% | 0.34% | – |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $4,352,000 | – | 94,202 | +100.0% | 0.32% | – |
| New | APTOSE BIOSCIENCES INC | $3,676,000 | – | 839,194 | +100.0% | 0.27% | – | |
| LHCG | Buy | LHC GROUP INC | $3,131,000 | +1.9% | 14,679 | +1.5% | 0.23% | -26.3% |
| PSCH | INVESCO EXCH TRADED FD TR IIetf | $2,937,000 | +28.6% | 17,285 | 0.0% | 0.22% | -7.3% | |
| IBB | ISHARES TRetf | $2,532,000 | +11.9% | 16,713 | 0.0% | 0.19% | -19.4% | |
| IHI | ISHARES TRetf | $2,481,000 | +9.2% | 7,580 | 0.0% | 0.18% | -21.0% | |
| XLV | SELECT SECTOR SPDR TRetf | $2,069,000 | +7.5% | 18,241 | 0.0% | 0.15% | -22.3% | |
| ATEC | New | ALPHATEC HLDGS INC | $1,924,000 | – | 132,500 | +100.0% | 0.14% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $969,000 | – | 6,200 | +100.0% | 0.07% | – |
| ABBV | ABBVIE INC | $641,000 | +22.3% | 5,981 | 0.0% | 0.05% | -13.0% | |
| UNH | Buy | UNITEDHEALTH GROUP INC | $541,000 | +150.5% | 1,543 | +123.0% | 0.04% | +81.8% |
| BDX | New | BECTON DICKINSON & CO | $416,000 | – | 1,662 | +100.0% | 0.03% | – |
| ANTM | Buy | ANTHEM INC | $399,000 | +86.4% | 1,244 | +56.5% | 0.03% | +36.4% |
| MRK | MERCK & CO. INC | $347,000 | -1.4% | 4,247 | 0.0% | 0.03% | -27.8% | |
| JNJ | JOHNSON & JOHNSON | $340,000 | +5.6% | 2,161 | 0.0% | 0.02% | -24.2% | |
| NVS | NOVARTIS AG | $334,000 | +8.8% | 3,535 | 0.0% | 0.02% | -19.4% | |
| CI | New | CIGNA CORP NEW | $325,000 | – | 1,560 | +100.0% | 0.02% | – |
| BIO | BIO RAD LABS INC | $319,000 | +13.1% | 548 | 0.0% | 0.02% | -17.2% | |
| SNY | SANOFI | $323,000 | -3.3% | 6,650 | 0.0% | 0.02% | -29.4% | |
| PFE | PFIZER INC | $312,000 | +0.3% | 8,469 | 0.0% | 0.02% | -28.1% | |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $303,000 | – | 8,985 | +100.0% | 0.02% | – |
| SYNH | New | SYNEOS HEALTH INC | $304,000 | – | 4,469 | +100.0% | 0.02% | – |
| NUVA | New | NUVASIVE INC | $294,000 | – | 5,228 | +100.0% | 0.02% | – |
| A | AGILENT TECHNOLOGIES INC | $302,000 | +17.5% | 2,548 | 0.0% | 0.02% | -15.4% | |
| GILD | New | GILEAD SCIENCES INC | $301,000 | – | 5,175 | +100.0% | 0.02% | – |
| CVS | New | CVS HEALTH CORP | $286,000 | – | 4,182 | +100.0% | 0.02% | – |
| BAX | BAXTER INTL INC | $261,000 | -0.4% | 3,258 | 0.0% | 0.02% | -29.6% | |
| AMGN | AMGEN INC | $251,000 | -9.7% | 1,092 | 0.0% | 0.02% | -32.1% | |
| HOLX | HOLOGIC INC | $243,000 | +9.5% | 3,340 | 0.0% | 0.02% | -21.7% | |
| PRGO | New | PERRIGO CO PLC | $236,000 | – | 5,275 | +100.0% | 0.02% | – |
| ICUI | New | ICU MED INC | $223,000 | – | 1,041 | +100.0% | 0.02% | – |
| HRC | New | HILL ROM HLDGS INC | $208,000 | – | 2,121 | +100.0% | 0.02% | – |
| GRFS | GRIFOLS S A | $187,000 | +6.2% | 10,166 | 0.0% | 0.01% | -22.2% | |
| DYNT | Exit | DYNATRONICS CORP | $0 | – | -461,675 | -100.0% | -0.03% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.05% | – |
| NNOX | Exit | NANO X IMAGING LTD | $0 | – | -105,500 | -100.0% | -0.25% | – |
| HGEN | Exit | HUMANIGEN INC | $0 | – | -400,000 | -100.0% | -0.44% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -67,662 | -100.0% | -0.94% | – |
| AMRN | Exit | AMARIN CORPORATION | $0 | – | -2,236,158 | -100.0% | -0.96% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -1,577,880 | -100.0% | -13.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.